On May 18, 2023, the United States Food and Drug Administration (FDA) approved RINVOQ, manufactured by Abbvie, as a once-daily treatment for adults with moderate or severely active Crohn’s...
Artificial intelligence (AI) and machine learning (ML) have become a growing component of nearly every industry. The ability to model and problem-solve using technology instead of trial and error has proven extremely valuable beyond the...
In an announcement issued earlier this year, Eli Lilly is celebrating the success of Mounjaro in achieving 15.7% weight loss across 72 weeks for obese or overweight adults with type 2 diabetes (T2D)....
In recent years, pharmaceutical industry members have identified a boom in the biologic and biosimilar space. Although they only comprise a small part of the pharmaceutical industry, biological drug...
On April 16, 2023, Merck announced plans to expand its immunology portfolio by acquiring Prometheus Biosciences, a biotechnology company focused on immune-mediated diseases. The deal, valued at $10.8...
Although prescription adherence is widely regarded as one of the most critical indicators for health outcomes, the rate of nonadherence and abandonment have continued to rise across the United States, leading to thousands of deaths and...
One day into his second term, Governor Gavin Newsom of California has announced a partnership between CalRx, a California Department of Healthcare Services program, and Civica, a healthcare nonprofit,...
On March 16, 2023, just days after the FDA approved another new nasal migraine medication, Pfizer recalled its Nurtec ODT medication. Under advisement from the United States Consumer Product Safety...
By January 2024, Novo Nordisk plans to cut the prices of insulin pens and vials by up to 75%. The company is echoing strategies reported by Eli Lilly earlier this month, attempting to widen access to...
Last month, WAND reported that Akorn Pharmaceuticals, a major domestic manufacturer of liquid albuterol, was shutting down. This closure — which followed 2020 reports that the company filed for...
Multiple sclerosis is an immune-mediated disease that affects nearly 1 million people in the United States and over 2.8 million worldwide. Given the complexity of treatment, specialty care teams play a vital role in disease management by...
On Wednesday, March 1, 2023, Eli Lilly, a major insulin manufacturer in the United States, announced that it would cut its insulin prices by 70% and cap out-of-pocket costs to $35 per month. By the end...
An ongoing study supported by the NIH in San Francisco assessed the efficacy of long-acting antiretroviral therapy (LA-ART), administered via injection, for treating HIV. The study compared LA-ART to...
With a new FDA-approved immunotherapy treatment designed to delay the onset of type 1 diabetes (T1D), patients — 8 years or older — can enjoy more years without the physical and financial burdens of living with...
On January 31, 2023, Amgen announced that its product AMJEVITA, a Humira biosimilar, is now available in the United States. This new availability threatens the stake that AbbVie has held for decades...
A publication in JAMA Network Open found that folate, vitamin B6, and vitamin B12 intake and serum levels are inversely related to metabolic syndrome (MetS) incidence, with higher intake levels...
On January 9, 2023, the American Academy of Pediatrics (AAP) released its clinical practice guidelines for evaluating and treating pediatric obesity. These updated practices encourage comprehensive...
Based on the results of a double-blind, placebo-controlled, the FDA granted the accelerated approval of Leqembi for Alzheimer’s disease, making it the second approved medication targeting the...
Human immunodeficiency virus (HIV), a viral infection that attacks and weakens the immune system, impacts 38.4 million people worldwide. According to the WHO, in 2021, 650,000 people globally died of an HIV-related illness. Despite high...
Over the past couple of years, healthcare industry members have had to become fast experts on treating respiratory diseases. With the progression of the COVID-19 pandemic and the lingering pulmonary effects associated with infection,...
